Prognostic Variables and Calcitonin in Medullary Thyroid Cancer

Objectives/Hypothesis: Medullary thyroid cancer (MTC) is a nonepithelial, neuroendocrine tumor with a more aggressive clinical behavior than differentiated thyroid cancer. The purpose of the study was to review a single institution's experience with MCT since 1969.

[1]  R. A’Hern,et al.  Medullary thyroid cancer: multivariate analysis of prognostic factors influencing survival. , 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[2]  I. Fleming,et al.  A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985‐1995 , 1998, Cancer.

[3]  G. Sterrett,et al.  Medullary carcinoma of the thyroid , 1998, Cancer.

[4]  M. Schlumberger,et al.  Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients , 1998 .

[5]  R. Tsang,et al.  Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control. , 1996, Thyroid : official journal of the American Thyroid Association.

[6]  M. Sironi,et al.  Multivariate analysis of patients with medullary thyroid carcinoma: Prognostic significance and impact on treatment of clinical and pathologic variables , 1996, Cancer.

[7]  H. Gharib,et al.  Medullary thyroid carcinoma: clinicopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970. , 1992, Mayo Clinic proceedings.

[8]  S. Wells,et al.  Early diagnosis and treatment of medullary thyroid carcinoma. , 1985, Archives of internal medicine.

[9]  M. Saad,et al.  Medullary Carcinoma of the Thyroid: A STUDY OF THE CLINICAL FEATURES AND PROGNOSTIC FACTORS IN 161 PATIENTS , 1984, Medicine.

[10]  M. Saad,et al.  Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid. , 1984, The Journal of clinical endocrinology and metabolism.

[11]  J. Carney,et al.  Multiple endocrine neoplasia type 2. , 1980, Clinics in endocrinology and metabolism.

[12]  Daan Brandenbarg.  The National. , 1892 .

[13]  O. Schober,et al.  Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register , 2004, The clinical investigator.

[14]  M. Schlumberger,et al.  Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonine. , 1998, Clinical endocrinology.

[15]  S. Wells,et al.  Multiple endocrine neoplasia type II. , 1976, Annual review of medicine.